Literature DB >> 20717667

Apoptosis of human lung adenocarcinoma A549 cells induced by prodigiosin analogue obtained from an entomopathogenic bacterium Serratia marcescens.

Wei Zhou1, Zhi-Xiong Jin, Yong-Ji Wan.   

Abstract

An entomopathogenic bacterial strain SCQ1 was isolated from silkworm (Bombyx mori) and identified as Serratia marcescens via 16S rRNA gene analysis. This strain produces a red pigment that causes acute septicemia of silkworm. The red pigment of strain SCQ1 was identified as prodigiosin analogue (PGA) with various reported biological activities. In this study, we found that low concentration of PGA showed significant anticancer activity in human lung adenocarcinoma A549 cells, but has little effect in human bone marrow stem cells, in vitro. By exposure to different concentrations of PGA for 24 h, morphological changes and the MTT assay showed that A549 cell line was very sensitive to PGA, with IC(50) value about 2.2 mg/L. Early stage of apoptosis was detected by flow cytometry while A549 cells were treated with PGA for 4 and 12 h, respectively. The proportion of dead cells was increased with treatment time or the concentrations of PGA, but it was inversely proportional to that of apoptotic cells. These results indicate that PGA obtained from strain SCQ1 induces apoptosis in A549 cells, but the molecular mechanisms of cell death are complicated, and the S. marcescens strain SCQ1 may serve as a source of the anticancer compound, PGA.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20717667     DOI: 10.1007/s00253-010-2806-x

Source DB:  PubMed          Journal:  Appl Microbiol Biotechnol        ISSN: 0175-7598            Impact factor:   4.813


  8 in total

1.  Expression, crystallization and preliminary crystallographic data analysis of PigI, a putative L-prolyl-AMP ligase from the prodigiosin synthetic pathway in Serratia.

Authors:  Ning Han; Tingting Ran; Xiangdi Lou; Yanyan Gao; Jianhua He; Lin Tang; Dongqing Xu; Weiwu Wang
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2014-04-17       Impact factor: 1.056

2.  Expression, crystallization and preliminary crystallographic data analysis of PigF, an O-methyltransferase from the prodigiosin-synthetic pathway in Serratia.

Authors:  Shaowei Liu; Tingting Ran; Xiang Shen; Langlai Xu; Weiwu Wang; Dongqing Xu
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2012-07-31

3.  Mitochondrial dysfunction in Trypanosoma cruzi: the role of Serratia marcescens prodigiosin in the alternative treatment of Chagas disease.

Authors:  Carlos Genes; Eduard Baquero; Fernando Echeverri; Juan D Maya; Omar Triana
Journal:  Parasit Vectors       Date:  2011-05-06       Impact factor: 3.876

Review 4.  Competitive Cell Death Interactions in Pulmonary Infection: Host Modulation Versus Pathogen Manipulation.

Authors:  Ethan S FitzGerald; Nivea F Luz; Amanda M Jamieson
Journal:  Front Immunol       Date:  2020-05-19       Impact factor: 7.561

5.  A Comprehensive Network Pharmacology-Based Strategy to Investigate Multiple Mechanisms of HeChan Tablet on Lung Cancer.

Authors:  Zhenjie Zhuang; Qianying Chen; Cihui Huang; Junmao Wen; Haifu Huang; Zhanhua Liu
Journal:  Evid Based Complement Alternat Med       Date:  2020-05-30       Impact factor: 2.629

6.  Vinylpyrroles: solid-state structures and aggregation-induced emission properties.

Authors:  Toru Okawara; Yurina Matsufuji; Kouhei Mizuno; Kenji Takehara; Toshihiko Nagamura; Seiji Iwasa
Journal:  RSC Adv       Date:  2019-07-23       Impact factor: 4.036

Review 7.  Production and Potential Applications of Bioconversion of Chitin and Protein-Containing Fishery Byproducts into Prodigiosin: A Review.

Authors:  San-Lang Wang; Van Bon Nguyen; Chien Thang Doan; Thi Ngoc Tran; Minh Trung Nguyen; Anh Dzung Nguyen
Journal:  Molecules       Date:  2020-06-13       Impact factor: 4.411

8.  PG-Priming Enhances Doxorubicin Influx to Trigger Necrotic and Autophagic Cell Death in Oral Squamous Cell Carcinoma.

Authors:  Shian-Ren Lin; Ching-Feng Weng
Journal:  J Clin Med       Date:  2018-10-21       Impact factor: 4.241

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.